Abstract

Glucokinase (GCK) controls the rate of glucose metabolism in pancreatic β cells, and its activity is rate-limiting for insulin secretion. Posttranslational GCK activation can be stimulated through either G protein-coupled receptors or receptor tyrosine kinase signaling pathways, suggesting a common mechanism. Here we show that inhibiting Ca(2+) release from the endoplasmic reticulum (ER) decouples GCK activation from receptor stimulation. Furthermore, pharmacological release of ER Ca(2+) stimulates activation of a GCK optical biosensor and potentiates glucose metabolism, implicating rises in cytoplasmic Ca(2+) as a critical regulatory mechanism. To explore the potential for glucose-stimulated GCK activation, the GCK biosensor was optimized using circularly permuted mCerulean3 proteins. This new sensor sensitively reports activation in response to insulin, glucagon-like peptide 1, and agents that raise cAMP levels. Transient, glucose-stimulated GCK activation was observed in βTC3 and MIN6 cells. An ER-localized channelrhodopsin was used to manipulate the cytoplasmic Ca(2+) concentration in cells expressing the optimized FRET-GCK sensor. This permitted quantification of the relationship between cytoplasmic Ca(2+) concentrations and GCK activation. Half-maximal activation of the FRET-GCK sensor was estimated to occur at ∼400 nm Ca(2+). When expressed in islets, fluctuations in GCK activation were observed in response to glucose, and we estimated that posttranslational activation of GCK enhances glucose metabolism by ∼35%. These results suggest a mechanism for integrative control over GCK activation and, therefore, glucose metabolism and insulin secretion through regulation of cytoplasmic Ca(2+) levels.

Highlights

  • It a non-allosteric sigmoidal dependence for glucose [1]

  • endoplasmic reticulum (ER) Ca2ϩ Couples Receptor Signaling to GCK Activation—To study dynamic GCK regulation, we utilized two methods we established previously as useful assays for studying GCK activation by NO in living cells

  • Because GCK is rate-limiting for glucose metabolism [25], changes in GCK activity are reflected by glucose-dependent rises in NAD(P)H [26]

Read more

Summary

Experimental Procedures

Specimens for Fluo-4 imaging were prepared by labeling cells with acetoxymethyl ester conjugate (Life Technologies, 5 ␮M, 30 min, 37 °C) according to the recommendations of the manufacturer. Quantitative fura-2/FRET imaging was performed essentially as described previously [23] but incorporated 360- and 380-nm LED illumination for collecting fura-2 fluorescence. ChR was activated by manual triggering of 455-nm LED fluorescence for ϳ1-s intervals as indicated, except for collection of quantitative data for curve fitting. For those experiments, the Zeiss AxioVison Smart Experiments function was used to precisely activate ChR using three trains of 15 1-s pulses.

Results
B Donor CFP
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call